EP1161375B1 - Emballage collecteur pour prelever des sachets remplis, selon un ordre predetermine - Google Patents

Emballage collecteur pour prelever des sachets remplis, selon un ordre predetermine Download PDF

Info

Publication number
EP1161375B1
EP1161375B1 EP00912571A EP00912571A EP1161375B1 EP 1161375 B1 EP1161375 B1 EP 1161375B1 EP 00912571 A EP00912571 A EP 00912571A EP 00912571 A EP00912571 A EP 00912571A EP 1161375 B1 EP1161375 B1 EP 1161375B1
Authority
EP
European Patent Office
Prior art keywords
bags
multipack
edges
bag
superposed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP00912571A
Other languages
German (de)
English (en)
Other versions
EP1161375A1 (fr
Inventor
Detlef Palm
Ronald Hackbarth
Michael Heberle
Detlev Neuland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of EP1161375A1 publication Critical patent/EP1161375A1/fr
Application granted granted Critical
Publication of EP1161375B1 publication Critical patent/EP1161375B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D33/00—Details of, or accessories for, sacks or bags
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D33/00—Details of, or accessories for, sacks or bags
    • B65D33/001—Blocks, stacks or like assemblies of bags

Definitions

  • the invention relates to a packaging of products which for protection in a bag, the packaging being at least two Bags.
  • the contents in these bags can be identical or different. Preferably, these contents are to be taken and used in a given order.
  • This type of bags are bags that have an interior and a possess this interior enclosing edge, z. B. to the expert known four-edge seal bag. Of course, these bags can also only be sealed three, two or one edge.
  • the products are preferably flat systems, for. B. Stickers, labels, tea towels, floppy disks, CD-ROMs, chip cards, Coins, stamps, flat systems for oral or transdermal Application or patch and the like.
  • these patches can z.
  • B. under a Hormone replacement therapy can be used in a way that in a first phase (duration about 14 days) on every third day Patch containing an estrogen, and in a second phase (Duration about 14 days) on each third day each containing a patch an estrogen and a gestagen is applied. With such a therapy So first you need about 4 plasters of the first phase and then about 4 Patches of the second phase are used.
  • the object of the invention is therefore to simplify the administration this patch in the proposed therapy plan and to avoid Confusions to provide a multipack that has a certain number of area systems, eg. B. a total of 8 plasters in the respective bags in the required order and in a block contains connected to each other.
  • a certain number of area systems eg. B. a total of 8 plasters in the respective bags in the required order and in a block contains connected to each other.
  • CH 339 119 is an album from a series of flat Bag revealed. These bags are made of transparent material and contain different plant seeds. They also indicate Pictures of the respective plant. It is not in the document described that the bags in a predetermined order too You can see the order of the bags within the album equivalent. Also, no flat systems are disclosed as products. On Fan fanning - as stated in this document Drawing is shown - therefore can not be prevented.
  • a packaging for products which individually in Bag or in several cells are packed on a blackboard.
  • characteristic for this packaging is a printed outer coat, which takes the form of a inverted U's and in which the individual bags or the panels with arranged thereon, product-filled cells are inserted at the top.
  • This Packaging may be equipped with a label closure and have a fastening system for a pin. Even if it is It should be noted that such packaging for bandages and pharmaceutical products are suitable, but the reference to Products, the two-dimensional systems for oral or transdermal application represent. An indication of a specific order in which the bags be placed inside the multipack, is completely missing. Also Here, the problem of fanning the individual bags is not addressed.
  • the bags have an interior and have an edge enclosing this interior, at least two bags are grouped into one block, within this one Blocks a section of the edge of a first bag to the section of the Rands of an adjacent second bag essentially nationwide on top of each other, and within this block so the one above the other lying portions of the edges of each adjacent bag firmly connected to each other.
  • This block can also be provided with a back.
  • the back can be replaced by a re-closable envelope be wrapped around the bags.
  • the closure of the envelope can additionally with a closure seal, so that the buyer of the Pack can detect if the packaging is still intact.
  • Such Seal is z.
  • the materials that make up the back or the envelope may consist of paper, cardboard, cardboard, plastic, metal, elastic plastic film, composite materials such as metal and / or plastic-coated paper, etc.
  • the block itself can be provided with a closure seal his.
  • a closure seal his there is such a seal (sticker) z.
  • This collective pack (so-called calendar pack, that is the block of several firmly connected bags) can subsequently in a conventional carton.
  • calendar pack that is the block of several firmly connected bags
  • For large packs can several of these collective packs in a carton summarized become.
  • the interior of the contents of the bag has a certain thickness owns a fuzz in a block containing multiple bags These bags occur, but by using spacers can be avoided.
  • the spacers preferably have a thickness that is the thickness of the contents of a bag equivalent. Adjusting the thickness of the adhesive layer or the adhesive film does not have to be done.
  • the user eg patient first removes the multipack of the Folding box. Due to the tamper-evident closure (ie the uninjured Closing seal), he can determine whether the multipack already open has been. After opening the seal, the user first removes the top bag, since this is offered to him and the easiest to remove is. Through the back or the envelope is prevented the user a bag from the back and thus in the wrong, d. H. takes in reverse order. When removing the first bag the composite of the remaining bags is not destroyed and the required Order remains. The remaining bags are then protected by the closure of the envelope.
  • the tamper-evident closure ie the uninjured Closing seal
  • the portion of the edge of a first bag with the portion of the edge of an adjacent second Bag so superimposed that the respective edges of these edges slightly parallel has the Advantage that when using an adhesive as a connecting device the Contact surface between glue and bag film is enlarged and thus a better hold of the bag is created. Also, this facilitates the use an adhesive tape as a connecting device.
  • the extent of Parallel displacement generally depends on the thickness of the bags and in a preferred embodiment is at least 0.3 each mm.
  • this manufacturing process will be after stacking the bags to be permanently attached to them shifted slightly parallel (preferably at least about each 0.3 mm), so that on subsequent joining the superimposed lying portions of the edges of the bag by means of z.
  • B. adhesives Contact surface between glue and bag is increased.
  • the bags of a multipack two different types of content (eg two TTS with different Active ingredients or Wirkstoffkombinatonnen) contained in a given order, the order of the bags within the Multipack (from the top toward the back) corresponds, taken Need to become.
  • two different types of content eg two TTS with different Active ingredients or Wirkstoffkombinatonnen
  • the multipack in a method for transdermal administration of hormones in which a first Treatment phase at least one transdermal therapeutic system (TTS) containing at least one estrogen and in one second treatment phase at least one transdermal therapeutic System is administered containing at least one estrogen and a progestin contains, used.
  • TTS transdermal therapeutic system
  • This is from the multipack at the beginning the first treatment phase at least one bag containing a transdermal therapeutic system with at least one estrogen and on the skin of a user applied, and from the said multipack at the beginning of the second Treatment phase at least one bag containing a transdermal therapeutic system with at least one estrogen and one Progestogen taken and applied to the skin of a user or a Applicant applied.
  • the concrete number of the bags of the collective pack is in this case according to which administration period the individual transdermal therapeutic systems are designed.
  • the transdermal therapeutic systems e.g. B. is plaster, which from the Users are worn three days each should be a total of two times four TTS or twice five TTS, with the number two on the different TTS types (containing estrogen or estrogen and gestagen).

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Packages (AREA)
  • Sheets, Magazines, And Separation Thereof (AREA)
  • Bag Frames (AREA)
  • Containers And Plastic Fillers For Packaging (AREA)
  • Examining Or Testing Airtightness (AREA)
  • Auxiliary Devices For And Details Of Packaging Control (AREA)
  • Supplying Of Containers To The Packaging Station (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)

Claims (12)

  1. Emballage groupé comprenant au moins deux poches (2, 5, 7, 11, 12) à prélever dans un ordre défini, qui correspond à la succession des poches à l'intérieur de l'emballage groupé, les poches (2, 5, 7, 11, 12) comportant un compartiment intérieur et un bord entourant ledit compartiment intérieur et au moins deux de ces poches étant regroupées pour former un bloc, sachant qu'à l'intérieur de ce bloc une partie du bord (9) d'une première poche est superposée sensiblement sur toute la surface sur la partie du bord (9) d'une deuxième poche voisine et les parties superposées des bords de chacune des poches voisines sont assemblées fermement l'une à l'autre, les poches étant remplies par des contenus différents, caractérisé en ce que les contenus sont des systèmes plats pour l'administration par voie orale ou transdermique.
  2. Emballage groupé selon la revendication 1, caractérisé en ce que les systèmes plats pour l'administration par voie transdermique sont des systèmes thérapeutiques transdermiques (TTS) contenant des hormones sexuelles.
  3. Emballage groupé selon la revendication 1 ou 2, caractérisé en ce que le bloc formé par au moins deux poches comporte en outre un dos (1, 8) ou un rabat (4) pouvant être refermé.
  4. Emballage groupé selon l'une quelconque des revendications 1 à 3, caractérisé en ce que le bloc formé par au moins deux poches comporte en outre un sceau de fermeture.
  5. Emballage groupé selon l'une quelconque des revendications 1 à 4, caractérisé en ce que les parties superposées des bords (9) de chacune des poches voisines sont assemblées au moyen d'une colle thermofusible, d'une bande adhésive, d'une colle, d'agrafes, d'un agent de scellement ou d'une bande adhésive double face.
  6. Emballage groupé selon l'une quelconque des revendications 1 à 5, caractérisé en ce que les poches comportent une ligne de perforation (10) dans un bord entourant le compartiment intérieur et les parties superposées des bords de chacune des poches voisines sont délimitées par cette ligne de perforation.
  7. Emballage groupé selon l'une quelconque des revendications 1 à 6, caractérisé en ce que chaque arête des parties superposées des bords (9) de poches voisines sont décalées parallèlement et/ou les parties superposées des bords comportent des écarteurs (13) agencés entre lesdites parties.
  8. Procédé de fabrication d'un emballage groupé comprenant au moins deux poches (2, 5, 7, 11, 12), sachant que les poches comportent un compartiment intérieur et un bord entourant ledit compartiment intérieur et sont remplies par un produit, ces produits étant des systèmes plats pour l'administration par voie orale ou transdermique, dans lequel procédé
    a) la partie du bord (9) d'une première poche contenant un produit est superposée sensiblement sur toute la surface sur la partie du bord (9) d'une deuxième poche voisine contenant un produit,
    b) les arêtes des parties à superposer des bords des poches contenant un produit sont décalées parallèlement en direction des bords situés en face, et
    c) les parties superposées des bords des poches contenant un produit sont assemblées durablement.
  9. Procédé de fabrication d'un emballage groupé selon la revendication 8, caractérisé en ce qu'une ligne de perforation (10) est réalisée en plus dans les parties à superposer des bords (9) des poches contenant un produit.
  10. Procédé de fabrication d'un emballage groupé selon la revendication 8 ou 9, caractérisé en ce que des écarteurs (13) sont insérés en plus entre les parties à superposer des bords (9) des poches contenant un produit.
  11. Utilisation d'un emballage groupé selon l'une quelconque des revendications 1 à 7 pour le prélèvement de poches individuelles dans un ordre défini, qui correspond à la succession des poches à l'intérieur de l'emballage groupé.
  12. Utilisation d'un emballage groupé selon la revendication 11 dans un procédé pour l'administration par voie transdermique d'hormones, dans laquelle
    a) au début d'une première phase de traitement, on prélève au moins une poche contenant un système thérapeutique transdermique avec au moins un oestrogène et
    b) au début d'une deuxième phase de traitement, on prélève au moins une poche contenant un système thérapeutique transdermique avec au moins un oestrogène et un gestagène.
EP00912571A 1999-03-17 2000-03-09 Emballage collecteur pour prelever des sachets remplis, selon un ordre predetermine Expired - Lifetime EP1161375B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19911799A DE19911799A1 (de) 1999-03-17 1999-03-17 Sammelpackung zur Entnahme von befüllten Beuteln in vorgebener Reihenfolge
DE19911799 1999-03-17
PCT/EP2000/002043 WO2000055061A1 (fr) 1999-03-17 2000-03-09 Emballage collecteur pour prelever des sachets remplis, selon un ordre predetermine

Publications (2)

Publication Number Publication Date
EP1161375A1 EP1161375A1 (fr) 2001-12-12
EP1161375B1 true EP1161375B1 (fr) 2003-09-17

Family

ID=7901234

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00912571A Expired - Lifetime EP1161375B1 (fr) 1999-03-17 2000-03-09 Emballage collecteur pour prelever des sachets remplis, selon un ordre predetermine

Country Status (10)

Country Link
US (2) US7004321B1 (fr)
EP (1) EP1161375B1 (fr)
JP (1) JP4494646B2 (fr)
KR (1) KR100665434B1 (fr)
AT (1) ATE249976T1 (fr)
AU (1) AU3428300A (fr)
DE (2) DE19911799A1 (fr)
DK (1) DK1161375T3 (fr)
ES (1) ES2207491T3 (fr)
WO (1) WO2000055061A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007131615A1 (fr) 2006-05-12 2007-11-22 Lts Lohmann Therapie-Systeme Ag Emballage collectif de sachets
DE102007037374A1 (de) * 2007-08-06 2009-02-12 Bayer Schering Pharma Aktiengesellschaft Vorrichtung und Verwendung zum Aufbewahren und Bereitstellen von Arzneimittel-Wafern
DE102009008026A1 (de) * 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung eines Stapels von Arzneimitteltaschen, Arzneimitteltaschenvorlage zur Herstellung des Stapels sowie Verwendung der Arzneimitteltaschenvorlage
DE102009008027A1 (de) * 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Vorrichtung und Verwendung zur Aufbewahrung und Bereitstellung von Arzneimittelwafern

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008116177A1 (fr) * 2007-03-21 2008-09-25 Wm. Wrigley Jr. Company Emballage de produit de confiserie
AU2010202571B2 (en) 2009-07-29 2015-10-01 Mcneil-Ppc, Inc. Packaging
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
EP3435977A4 (fr) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. Composition pharmaceutique d'hormone stéroïde
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447712A (en) * 1891-03-03 Oie coupling
GB447712A (en) * 1935-06-20 1936-05-25 William Warren Triggs Improvements relating to the packaging of articles
US2715493A (en) 1948-12-23 1955-08-16 Clarence W Vogt Chained enwrapments
US2653751A (en) * 1949-01-14 1953-09-29 Clarence W Vogt Chain of bags
DE1027844B (de) * 1954-05-12 1958-04-10 Hans Neschen Vorratspackung fuer mehrere uebereinandergelegte Wundpflaster
DE1683678U (de) * 1954-06-28 1954-09-23 Willi Maurer K G Briefartige kleinpakkung, insbesondere fuer pulverfoermige stoffe.
CH339119A (fr) 1957-08-13 1959-06-15 Vatter Richard Carnet pour la présentation et la vente de graines végétales
DE1823247U (de) * 1960-06-01 1960-12-08 Global Synthetic G M B H Taschen- bzw. beutelfoermige serienverpackung fuer handelsgueter.
JPS4928905Y1 (fr) * 1969-06-23 1974-08-06
AT330646B (de) * 1972-04-08 1976-07-12 Windmoeller & Hoelscher Abreissblock fur beutel, insbesondere aus kunststoff-folie
US3915302A (en) * 1974-10-07 1975-10-28 Vac Pac Mfg Co Imbricated package of closed-end bags
ZA763874B (en) 1975-07-03 1977-05-25 American Minechem Corp Method for transporting coal
JPS5280587U (fr) * 1975-12-12 1977-06-16
GB1574347A (en) * 1977-10-06 1980-09-03 Salve Sa Package
US4502599A (en) * 1984-04-02 1985-03-05 Minnesota Mining And Manufacturing Company Package and method of packaging resealable plastic bags
JPS62128544U (fr) * 1986-02-07 1987-08-14
HU214598B (hu) * 1987-09-24 1998-04-28 Jencap Research Ltd Eljárás fogamzásgátló és hormonterápiához alkalmazható, ösztrogént és progesztint tartalmazó gyógyszerkészítmények előállítására
US5422119A (en) * 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
FR2629797A1 (fr) * 1988-04-07 1989-10-13 Raffegeau Didier Surconditionnement de produits emballes individuellement en sachets ou en plaquettes alveolaires
DE8811648U1 (de) * 1988-09-14 1988-11-10 Franz, Lotte, 6082 Walldorf Verpackungseinheit für Papiertaschentücher
JPH0285157A (ja) * 1988-09-20 1990-03-26 Asahi Chem Ind Co Ltd 積重ねた収納袋
EP0409383B1 (fr) 1989-07-21 1994-04-06 Izhak Blank Compositions à base d'estradiol et procédés d'application topique
EP0800149A3 (fr) 1990-03-22 1997-11-12 Kabushiki Kaisha Oh-Yoh Keisoku Kenkyusho Système de détection de mouvement
DE4223004A1 (de) 1992-07-13 1994-01-20 Liedtke Pharmed Gmbh Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie
JPH085453B2 (ja) * 1993-03-30 1996-01-24 株式会社三橋製作所 小袋セットおよびその供給装置
JPH08187269A (ja) * 1994-11-10 1996-07-23 Aanesu:Kk 薬収納用ファイル
DE9418312U1 (de) * 1994-11-15 1995-12-14 Beiersdorf Ag, 20253 Hamburg Pflasterverpackung
JP3763726B2 (ja) 1999-07-14 2006-04-05 キヤノンファインテック株式会社 インクジェット記録装置

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007131615A1 (fr) 2006-05-12 2007-11-22 Lts Lohmann Therapie-Systeme Ag Emballage collectif de sachets
DE102006022198B4 (de) * 2006-05-12 2008-08-21 Lts Lohmann Therapie-Systeme Ag Beutel-Sammelpackung
US8944247B2 (en) 2006-05-12 2015-02-03 Lts Lohmann Therapie Systeme Ag Pouch-based cumulative packaging
DE102007037374A1 (de) * 2007-08-06 2009-02-12 Bayer Schering Pharma Aktiengesellschaft Vorrichtung und Verwendung zum Aufbewahren und Bereitstellen von Arzneimittel-Wafern
DE102007037374B4 (de) * 2007-08-06 2009-04-23 Bayer Schering Pharma Aktiengesellschaft Vorrichtung und Verwendung zum Aufbewahren und Bereitstellen von Arzneimittel-Wafern
DE102009008026A1 (de) * 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung eines Stapels von Arzneimitteltaschen, Arzneimitteltaschenvorlage zur Herstellung des Stapels sowie Verwendung der Arzneimitteltaschenvorlage
DE102009008027A1 (de) * 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Vorrichtung und Verwendung zur Aufbewahrung und Bereitstellung von Arzneimittelwafern

Also Published As

Publication number Publication date
ATE249976T1 (de) 2003-10-15
DK1161375T3 (da) 2003-12-15
DE50003727D1 (de) 2003-10-23
KR20020007328A (ko) 2002-01-26
KR100665434B1 (ko) 2007-01-04
AU3428300A (en) 2000-10-04
US7004321B1 (en) 2006-02-28
WO2000055061A1 (fr) 2000-09-21
EP1161375A1 (fr) 2001-12-12
US6905705B2 (en) 2005-06-14
US20040232028A1 (en) 2004-11-25
DE19911799A1 (de) 2000-09-28
JP2002539050A (ja) 2002-11-19
ES2207491T3 (es) 2004-06-01
JP4494646B2 (ja) 2010-06-30

Similar Documents

Publication Publication Date Title
EP1161375B1 (fr) Emballage collecteur pour prelever des sachets remplis, selon un ordre predetermine
EP1140650B1 (fr) Emballage d'objets/de produits plats
DE69309640T2 (de) Verschlussetikett
DE19983228B4 (de) Einzeln verpackter, absorbierender Artikel, und ein Verfahren zu dessen Herstellung
EP1094430B1 (fr) Etiquette en plusieurs parties pour Emballage-Coque, méthode de fabrication et utilisation
DE60310144T2 (de) Abgabebehälter
DE4429503C2 (de) Packung, insbesondere Arzneimittelpackung
DE2622109A1 (de) Damenbinde
CH642026A5 (de) Leere verpackung zum einlegen von blisterstreifen und blisterpackung.
DE202004021140U1 (de) Neue Arzneimittelverpackung
DE60123114T2 (de) Verpackungsmittel zur aufnahme einer blisterpackung
EP2175827B1 (fr) Dispositif de conservation et distribution de médicaments sous forme de pastilles et son utilisation
DE69201753T2 (de) Vorrichtung zum Verschliessen und Öffnen eines Beutels aus Kunststoffolie.
EP1233914A1 (fr) Emballage de mouchoirs en papier humidifie ou d'autres produits de consommation semblables
DE60011888T2 (de) Etiketten und etikettierte verpackungen
DE2418999A1 (de) Roentgenfilmverpackung
DD283562A5 (de) Primaerverpackung fuer flaechenstabilisierte verbandstoffe
EP0307352B1 (fr) Emballage pour médicaments
EP1107213A2 (fr) Etiquette formée par plusieurs parties, sa fabrication et son usage
EP0520330B1 (fr) Pansements et matériaux adhésifs médicaux emballés, et leur fabrication
EP1824756A1 (fr) Unite d'emballage primaire pour des formes galeniques plates
DE60300075T2 (de) Abgabebehälter
EP1227991A1 (fr) Procede d'emballage d'objets et materiau d'emballage en forme de bande
DE10056234A1 (de) Primärverpackung für transdermale therapeutische Systeme oder medizinische Pflaster
DE102010028351A1 (de) Wafertasche

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010911

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20020410

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20030917

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20030917

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 50003727

Country of ref document: DE

Date of ref document: 20031023

Kind code of ref document: P

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: GERMAN

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20031217

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20031226

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20031215

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20030917

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040309

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040331

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2207491

Country of ref document: ES

Kind code of ref document: T3

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20040618

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20120322

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20120322

Year of fee payment: 13

REG Reference to a national code

Effective date: 20130331

Ref country code: DK

Ref legal event code: EBP

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130309

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130331

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20190321

Year of fee payment: 20

Ref country code: IT

Payment date: 20190325

Year of fee payment: 20

Ref country code: FR

Payment date: 20190322

Year of fee payment: 20

Ref country code: GB

Payment date: 20190320

Year of fee payment: 20

Ref country code: CH

Payment date: 20190320

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20190321

Year of fee payment: 20

Ref country code: NL

Payment date: 20190320

Year of fee payment: 20

Ref country code: SE

Payment date: 20190320

Year of fee payment: 20

Ref country code: BE

Payment date: 20190320

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20190418

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 50003727

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MK

Effective date: 20200308

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20200308

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK07

Ref document number: 249976

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200309

REG Reference to a national code

Ref country code: BE

Ref legal event code: MK

Effective date: 20200309

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20200308

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20200721

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20200310